Navigation Links
Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
Date:7/11/2008

SAN FRANCISCO, July 11 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), today announced that it has dosed the first acute setting heart failure patient in its Phase IIa, multi-center, open-label, ascending dose clinical study of the company's lead product candidate, CD-NP, a novel chimeric natriuretic peptide, in development for the treatment of acute decompensated heart failure.

The primary objective of the Phase IIa study is to assess hemodynamic effects of intravenous infusions of CD-NP in patients with heart failure. Key assessments include measurement of pulmonary capillary wedge pressure (PCWP), plasma cGMP, a secondary messenger of the target receptor, blood pressure, heart rate, serum potassium and renal function. Nile expects up to 30 heart failure patients will be enrolled in the trial.

Results from the Phase Ia study in 22 healthy volunteers were consistent with several pre-clinical findings, including that CD-NP was associated with increased levels of plasma cGMP, preserved renal function, increased natriuresis and diuresis with minimal effect on mean arterial pressure. In parallel with the Phase IIa study, Nile is completing its Phase Ib study of CD-NP. The primary objectives of the Phase Ib study are to assess the safety and tolerability of intravenous infusions of CD-NP in patients with heart failure. Results from both the Phase Ib and Phase IIa trials are expected to be available in 2008.

"We are pleased to have reached this important corporate milestone and to be able to begin this Phase II trial of CD-NP in heart failure patients," said Peter Strumph, Chief Executive Officer of Nile. "We look forward to rapidly enrolling this Phase II trial and to further investigating the clinical e
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
2. Silence Therapeutics Announces Board Changes
3. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
4. Data Presented at American Headache Societys Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics Tezampanel
5. TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate
6. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
7. Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health
8. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
9. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
10. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
11. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015  Rigrodsky & Long, P.A.: ... Inc. (NASDAQ GM: AERI )? , Did you purchase ... , Did you lose money in your investment in Aerie ... Rigrodsky & Long, P.A. , including ... announces that a complaint has been filed in the United States ...
(Date:5/6/2015)... Africa , May 6, 2015 In ... HIV/AIDS, malaria and tuberculosis combined[1]. Approximately 40 percent of cancer ... with the right treatment[3]. Together with Elekta, ministries of health ... up their radiation therapy infrastructures and save lives. ... benefit from radiation therapy[4] during the course of their disease, ...
(Date:5/6/2015)... DUBLIN , May 06, 2015 Research and Markets ... the "Energy based Ablation Devices - Global Strategic Business ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , and Rest of ... 2014 through 2020. Also, a seven-year historic analysis is provided ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aerie Pharmaceuticals, Inc. 3Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
... Wis., Aug. 27 Inc. Magazine ... annual Inc. 5000, an exclusive ranking of the ... most comprehensive look at the most important segment ... convenience store chain 7-Eleven, Brooklyn Brewery, and Radio ...
... WICHITA, Kan., Aug. 27 Inc. Magazine/Inc.com selects online ... the 5,000 fastest growing companies in the United States. ... this is the second time that a store from ... 2008, iFurn.com, Inc. was awarded as an ...
Cached Medicine Technology:PercipEnz Makes Inc. Magazine's Fourth Annual List of America's Fastest-Growing Private Companies—the Inc. 5000 2PercipEnz Makes Inc. Magazine's Fourth Annual List of America's Fastest-Growing Private Companies—the Inc. 5000 3PercipEnz Makes Inc. Magazine's Fourth Annual List of America's Fastest-Growing Private Companies—the Inc. 5000 4PainReliever.com Earns Inc. 5000 Award 2
(Date:5/6/2015)... Dallas, TX (PRWEB) May 06, 2015 ... 2, Issue 1 of Patient Experience Journal (PXJ), ... and proven practices around understanding and improving patient experience. ... elevating the patient experience conversation globally, helps align the ... and impact. , Published in association with The ...
(Date:5/6/2015)... Animals make just as good friends as they ... your health. An Ohio veterinarian has been observing ... with health advantages of owning a pet. , “When animals ... pet ownership, there are proven health benefits for people-- including ... of the Animal Medical Center of Streetsboro said. ...
(Date:5/6/2015)... Is Colorado’s legal cannabis industry the victim ... State will mark the 18-month milestone of its historic ... while Colorado’s legal marijuana industry has been successful and ... facing some new challenges. , For example, many marijuana ... in the wake of last month’s “420” cannabis celebrations. ...
(Date:5/6/2015)... Inversion Studios, a full-service training ... Pilates classes, provides personalized individual instruction and now ... its new Pilates Ring magic circle. , Inversion ... stronger, more centered and graceful, Inversion Studios and ... to healthy fitness through yoga and Pilates. With ...
(Date:5/6/2015)... vcfo, a specialized consulting firm that provides access ... optimize business performance and productivity, announced the additions of ... Both Lynch and Scheaffer have more than 25 years ... are delighted to add Jack and Mike to the ... in financial management and leadership, Mike and Jack will ...
Breaking Medicine News(10 mins):Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:vcfo Adds Two Senior Executives to Growing Team 2
... April 1, 2008 Many top-selling drugs used to ... compounds called polyketides, which are found in nature but ... large quantities. , For the first time, scientists at ... shape, making it easier for chemists to manipulate them ...
... CHICAGO, Ill. (April 1, 2008) The largest-ever randomized ... patients with narrowing of the renal artery has shown ... therapy. Among patients who completed one year of follow-up, ... function, blood pressure control or the rates of major ...
... A new bioabsorbable plug that seals the arterial ... during diagnostic angiography and interventional procedures significantly shortens bleeding ... around far sooner than when manual compression is applied ... site complications at 30 days in the ECLIPSE Trial, ...
... PLC (OTC,Bulletin Board: SNKTY), a Life Sciences company ... science of healthy aging, today announced,that its North ... an,amount up to $28 million to further advance ... including Invicorp(R)., Plethora Solutions Holdings PLC, a ...
... inspires others to hit the trails for ... Valley Forge Revolutionary 5-mile Run, VALLEY ... tragedies, 55-year-old Skippack, Pa., resident Denny Chipollini,considers gifts. Chipollini has ... leg in a near-fatal car accident and the,contraction of Hepatitis ...
... to participate in Y Healthy Kids(R) Day Saturday, ... April ... Shield has teamed up with 17 YMCAs throughout Maine to fight,childhood obesity and ... the 17th annual YMCA Healthy,Kids Day on Saturday, April 12., "Healthy Kids ...
Cached Medicine News:Health News:Scientists solve mystery of polyketide drug formation 2Health News:Renal artery stenting falls short in large randomized trial 2Health News:Renal artery stenting falls short in large randomized trial 3Health News:ExoSeal vascular plug gets good reviews in ECLIPSE study 2Health News:Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts 2Health News:Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts 3Health News:Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts 4Health News:For Inspiring Amputee It's No Excuses, No Limits 2Health News:Anthem Sponsors Healthy Kids Day at Maine's YMCAs 2Health News:Anthem Sponsors Healthy Kids Day at Maine's YMCAs 3
... Vacuum Manifold system for sample processing consists ... a vacuum is applied, a chemical-resistant polypropylene ... convenience in sample handling. The manifold is ... up to 12 samples simultaneously. Loading, washing, ...
For regulating sample flow rate when using the QIAvac 24 Plus;...
For processing mini spin columns on QIAvac 6S;...
For monitoring vacuum pressure, suitable for use with all QIAvac manifolds;...
Medicine Products: